ClotTriever® Thrombectomy System
Designed for every clot.
Backed by data.
ClotTriever
is effective on clots of all ages ▸
is effective on clots of all ages ▸
% of limbs with complete or near-complete (≥ 75%) thrombus removal (as assessed by Marder Score)1
Better outcomes
drive efficiency.
Restore normal vein and valve function.
99.4%
Single-session treatment
n = 499
The lowest 2-year PTS rates ever reported in a major DVT study.2
94%
None or mild PTS symptoms at 2 years2
VenaCore® Thrombectomy Catheter
10x
Luminal area increase
VenaCore is designed to improve patency and increase luminal area by effectively disrupting and removing challenging venous occlusions.3
Innovation for an unmet medical need
The persistence of venous thrombotic obstruction detected several months after a DVT can lead to long-term complications. Patients with residual venous obstruction (RVO) have a 2x increased risk of developing post-thrombotic syndrome.4
RevCore® Thrombectomy Catheter
95% Stent patency post procedure
Complete control
Accurate and immediate torque response in targeted segment.
Right size, every time
Expandable element diameter up to 20 mm.
The first mechanical thrombectomy device for venous stent thrombosis
Uniquely designed for venous stents
The nitinol element in the RevCore thrombectomy catheter provides seamless interaction with implanted venous stents for the treatment of in-stent thrombosis.
Triever Catheters
Versatile toolkit
Triever aspiration catheters
Bloodless thrombectomy
40mL
Estimated blood loss
Focus on clot removal and patient outcomes without the concern of blood loss with FlowSaver®.
Efficiency meets power
Aspiration Flow Rate (cc/second)*
Governed by Poiseuille’s Law: Flow rate = π * r4 * ΔP / ( 8 * L); 8' tubing used under pump-based continuous aspiration. 1. Experimental data on file 03/08/2022. Continuous aspiration system included catheter and 8’ tubing under continuous pump-based aspiration.
Contact
Contact
Connect with an expert
Thank you!
Follow us on social media
Engage with us on social media to find information about upcoming MedEd events, including webinars, and to be among the first to receive news on technology enhancements, new clinical data and more.
References
- Thomas S. Maldonado, David J. Dexter, Herman Kado, Jonathan Schor, Suman Annambhotla, Hamid Mojibian, Robert E. Beasley, Outcomes from the ClotTriever Outcomes Registry show symptom duration may underestimate deep vein thrombus chronicity, Journal of Vascular Surgery: Venous and Lymphatic Disorders, Volume 10, Issue 6, 2022.
- Dexter D. Final Two Year CLOUT Outcomes. Presented at VIVA 2024 (Las Vegas, NV).
- Abramowitz S et al. Feasibility of a Novel Mechanical Thrombectomy Catheter to Debulk Venous Occlusions, Journal of Vascular Surgery, 82e41.
- Iding AFJ, et.al., Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study. Thromb Haemost. 2023.
Indications for use
The ClotTriever Thrombectomy System is indicated for: (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever Thrombectomy System is intended for use in the peripheral vasculature including deep vein thrombosis (DVT). The ClotTriever Sheaths are indicated for use as a conduit for the insertion of endovascular devices into the vasculature while minimizing blood loss associated with such insertions. The RevCore thrombectomy catheter is indicated for (1) the non-surgical removal of thrombi and emboli from blood vessels and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The RevCore thrombectomy catheter is intended for use in the peripheral vasculature. The VenaCore thrombectomy™ catheter is indicated for (1) the non-surgical removal of thrombi and emboli from blood vessels; (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from blood vessels. The VenaCore thrombectomy catheter is intended for use in the peripheral vasculature. Triever Catheters are intended for use in treating clot in transit in the right atrium but not in conjunction with FlowTriever Catheters. The Triever20 Curve is used coaxially within the Triever24 for (1) the non-surgical removal of emboli and thrombi from blood vessels and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Triever20 Curve is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever20 Curve Catheter is not indicated for use with FlowTriever Catheters. Triever20 Curve is also intended for use in treating clot in transit in the right atrium but not in conjunction with FlowTriever Catheters. Triever20 Curve must be used within the Triever24. The FlowSaver Blood Return System is used with Triever Catheters for autologous blood transfusion. The Triever16 Curve is indicated for (1) the non-surgical removal of emboli and thrombi from blood vessels and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Triever16 Curve is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever16 Curve is not indicated for use with FlowTriever Catheters. The Triever16 Curve is also intended for use in treating clot in transit in the right atrium but not in conjunction with FlowTriever Catheters. The FlowSaver® Blood Return System is used with Inari Medical catheters and sheaths for autologous blood transfusion. Contraindications: Not intended for use without anticoagulation. The FlowStasis device is intended for temporary suture retention following a percutaneous venous procedure.
Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of these products.
Caution
Federal (USA) law restricts this device to sale by or on the order of a physician.
Peripheral Vascular
This document is intended solely for the use of healthcare professionals. A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate Stryker’s products. A healthcare professional must always refer to the package insert, product label and/or instructions for use, including the instructions for cleaning and sterilization (if applicable), before using any of Stryker’sproducts. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your representative if you have questions about the availability of Stryker’s products in your area. Stryker or its affiliated entities own, use or have applied for the following trademarks or service marks: FlowStasis, FlowTriever, FlowTriever2, Intri24, Stryker, Triever16, Triever16 Curve, Triever20, Triever20 Curve and Triever24. All other trademarks are trademarks of their respective owners or holders. The absence of a product, feature, service name or logo from this list does not constitute a waiver of Stryker’s trademark or other intellectual property rights concerning that name or logo.
PRO-4492-USA-EN-v1